INNISFREE DAILY UV INVISIBLE BARRIER SUNSCREEN SERUM

AVOBENZONE, HOMOSALATE, AND OCTISALATE TOPICAL HUMAN OTC DRUG

INNISFREE DAILY UV INVISIBLE BARRIER SUNSCREEN SERUM is an FDA drug label for the active ingredient AVOBENZONE, HOMOSALATE, AND OCTISALATE manufactured by Innisfree Corporation administered by TOPICAL. This page reproduces the FDA-approved indications and usage, dosage, contraindications, warnings, and adverse reactions exactly as published in the drug label. Data source: openFDA (U.S. FDA), label effective 20260521.

Generic name
AVOBENZONE, HOMOSALATE, AND OCTISALATE
Manufacturer
Innisfree Corporation
Product type
HUMAN OTC DRUG
Route
TOPICAL
Dosage form
N/A
NDC
71220-091
Application
M020
Label effective
20260521

About this product

INNISFREE DAILY UV INVISIBLE BARRIER SUNSCREEN SERUM is an FDA-registered drug product whose active ingredient is AVOBENZONE, HOMOSALATE, AND OCTISALATE. It is labelled by Innisfree Corporation taken by topical and marketed as a human otc drug product. Identifiers on file: NDC 71220-091, application M020, label effective 20260521. It is one of 6 FDA drug label records sharing the active ingredient AVOBENZONE, HOMOSALATE, AND OCTISALATE. This page reproduces the FDA-approved label text so you can check what a product is, who makes it and how it is supplied before discussing it with a pharmacist or prescriber.

What it is used for

Across FDA labelling, products containing AVOBENZONE, HOMOSALATE, AND OCTISALATE are most often described in connection with: helps prevent, sun protection, measures see, directions decreases, risk skin, aging caused. Wording differs between labels, and the full indications section on this page takes precedence when it is present.

Active ingredients

ACTIVE INGREDIENTS Avobenzone 2.5% Homosalate 5.0% Octisalate 4.5%

Indications & Usage

USES Helps prevent sunburn If used as directed with other sun protection measures (see Directions ), decreases the risk of skin cancer and early skin aging caused by the sun

Dosage & Administration

DIRECTIONS ■ Apply liberally 15 minutes be- fore sun exposure. ■ Reapply at least every 2 hours. ■ Use a water-resistant sunscreen if swimming or sweating. ■ Sun Protection Measures. Spending time in the sun increases your risk of skin cancer and early skin aging. To decrease this risk, regul- arly use a sunscreen with a Broad Spectrum SPF value of 15 or higher and other sun protection measures including: Limit time in the sun, espe- cially from 10 a.m. - 2 p.m. Wear long-sleeved shirts, pa- nts, hats, and sunglasses. ■ Children under 6 months of age: Ask a doctor.

Warnings

WARNINGS For external use only Do not use on damaged or broken skin. When using this product keep out of eyes. Rinse with water to remove. Stop use and ask a doctor if rash occurs. Keep out of reach of children. If swallowed, call a poison control centre or get medical help right away.

More products with the same ingredient

AVOBENZONE, HOMOSALATE, AND OCTISALATE

ILLUSION LUMINOUS GLOW FOUNDATION

Kingdom Animalia, LLC DBA Hourglass Cosmetics View label

Mineral Radiance Energizing Day BS SPF 15

AHAVA Dead Sea Laboratories Ltd View label

SUPERDEFENSE BROAD SPECTRUM SPF 25 FATIGUE PLUS 1ST SIGNS OF AGE MULTI-CORRECTING VERY DRY TO DRY COMBINATION

CLINIQUE LABORATORIES LLC View label

Tula 24-7 Moisture Plus SPF 30 Hydrating Day with Sunscreen Broad Spectrum SPF 30

PML NYC, LLC View label

Tula Skincare Protect and Glow Daily Facial Sunscreen Gel SPF 30

The Procter & Gamble Manufacturing Company View label

How products containing AVOBENZONE, HOMOSALATE, AND OCTISALATE compare

FDA lists 6 drug label records with AVOBENZONE, HOMOSALATE, AND OCTISALATE as the active ingredient. The most common dosage forms and the manufacturers with the most records are summarised below; strengths, pack sizes and inactive ingredients can still differ between apparently similar products.

Dosage formProductsManufacturerProducts
— — AHAVA Dead Sea Laboratories Ltd 1
— — CLINIQUE LABORATORIES LLC 1
— — Innisfree Corporation 1
— — Kingdom Animalia, LLC DBA Hourglass Cosmetics 1
— — PML NYC, LLC 1

Frequently asked questions

What is INNISFREE DAILY UV INVISIBLE BARRIER SUNSCREEN SERUM used for?
USES Helps prevent sunburn If used as directed with other sun protection measures (see Directions ), decreases the risk of skin cancer and early skin aging caused by the sun

Who makes INNISFREE DAILY UV INVISIBLE BARRIER SUNSCREEN SERUM?
Innisfree Corporation is the labeler of record for INNISFREE DAILY UV INVISIBLE BARRIER SUNSCREEN SERUM. 6 FDA label records share the active ingredient AVOBENZONE, HOMOSALATE, AND OCTISALATE, so generic and branded versions may come from different companies; the manufacturer named on your pack is the one that matters for any enquiry.

What form does INNISFREE DAILY UV INVISIBLE BARRIER SUNSCREEN SERUM come in?
administered by topical. Strengths and pack sizes vary by label, so compare the NDC on your pack with the identifier listed on this page.

Is INNISFREE DAILY UV INVISIBLE BARRIER SUNSCREEN SERUM prescription or over-the-counter?
The FDA label for this product is recorded as human otc drug. Marketing status can differ between strengths and countries, so check the dispensing rules where you live.

Are there other products containing AVOBENZONE, HOMOSALATE, AND OCTISALATE?
Yes. 6 FDA drug label records list AVOBENZONE, HOMOSALATE, AND OCTISALATE as the active ingredient. Products with the same active ingredient can usually be substituted only when a prescriber or pharmacist confirms it is appropriate.

Has INNISFREE DAILY UV INVISIBLE BARRIER SUNSCREEN SERUM been recalled?
No FDA recall record in our database matches this product name or manufacturer. Recall data is updated periodically, so a very recent notice may not appear here yet.

Where does this information come from?
All content is reproduced from FDA Structured Product Labelling data via openFDA. It is provided for identification and reference only and is not medical advice.

This page reproduces FDA Structured Product Labelling data for identification and reference. It is not medical advice, does not diagnose or treat any condition, and does not sell or price any medicine.